CTRI/2023/07/054630尚未招募Unknown
A Clinical study on the management of Iron Deficiency Anemia in children using Homoeopathic constitutional medicines.
WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children of age group of 5 to 17 years are included.
- •Children of both sexes are included.
- •Children with mild and moderate anemia will be included by assessing their hemoglobin
- •levels mild anemia ;11.0-11.9 g/dl, moderate anemia; 9.0-10.9g/dL.
排除标准
- •Patients with severe complications of anemia
- •Patients who had history of any bleeding disorder
- •Patients associated with any other systemic disorder.
- •Patients who are in need for blood transfusion
- •Patients suffering from other disease such as SLE, Renal failure, Diabetes mellitus,
- •secondary hypertension.
研究者
相似试验
尚未招募
2 期
A Study on Iron deficiency anaemia classified and Managed with HomoeopathyCTRI/2024/07/071486DEPARTMENT OF ORGANON OF ORGANON OF MEDICINE AND HOMOEOPATHY PHILOSOPHY
进行中（未招募）
1 期
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT
尚未招募
不适用
Iron Deficiency AnemiaCTRI/2022/10/046444PG dept of Moalejat General Medicine
招募中
不适用
To study Effect of injectable iron for improving quality of life and mortality in patients with heart failure with reduced ejection fraction with iron deficiency.CTRI/2022/06/043440PGIMER CHANDIGARH
已完成
4 期
Effects of iron deficiency and its treatment on fibroblast growth factor 23 (FGF23) in patients treated with chronic haemodialysis therapy.ACTRN12614000548639Eastern Health Integrated Renal Service40